- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/22 - Nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 307/22
Total number of patents in this class: 87
10-year publication summary
|
7
|
12
|
9
|
4
|
8
|
5
|
10
|
7
|
3
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4789 |
7 |
| BASF SE | 21165 |
5 |
| Suzhou Abogen Biosciences Co., Ltd. | 75 |
5 |
| Fgh Biotech, Inc. | 12 |
4 |
| Eisai R&D Management Co., Ltd. | 1172 |
4 |
| Pfizer Inc. | 3375 |
3 |
| Cytokinetics, Inc. | 256 |
3 |
| Conopco, Inc. | 5012 |
2 |
| Purdue Research Foundation | 3874 |
2 |
| Arena Pharmaceuticals, Inc. | 348 |
2 |
| Domain Therapeutics | 60 |
2 |
| Eli Lilly and Company | 4050 |
2 |
| Okinawa Institute of Science and Technology School Corporation | 170 |
2 |
| Vincere Biosciences, Inc. | 7 |
2 |
| Merck Sharp & Dohme LLC | 3737 |
2 |
| Schlumberger Technology Corporation | 11584 |
1 |
| Unilever PLC | 3037 |
1 |
| Unilever N.V. | 2947 |
1 |
| Bayer AG | 3470 |
1 |
| Bayer Cropscience AG | 1878 |
1 |
| Other owners | 35 |